Find the right Medicare plan for 2026 — compare coverage and costs in minutes.

Compare Medicare Plans →
Medicare News MedCity News

Merck Pill Becomes First Oral Option in Growing Class of Cholesterol-Lowering Drugs

Merck’s Lipfendra is the first FDA-approved pill in the class of cholesterol-lowering drugs called PCSK9 inhibitors. While peptides are typically injected, Lipfendra is a macrocyclic peptide designed for formulation as an oral drug. The post Merck Pill Becomes First Oral Option in Growing Class of Cholesterol-Lowering Drugs appeared first on MedCity News .

Read full article →
Senior Health MedPageToday.com - medical news for physicians

Real Care Happens in the Moments in Between

(MedPage Today) -- This has been the worst year of my life medically. In the span of months, I was diagnosed with breast cancer, underwent a double mastectomy, required revision surgery, developed a post-surgical infection, and found myself hospitalized...

Read full article →